Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gossamer Bio Inc.

2.42
+0.03001.26%
Post-market: 2.37-0.0500-2.07%17:30 EDT
Volume:2.17M
Turnover:5.27M
Market Cap:550.26M
PE:-3.96
High:2.49
Open:2.40
Low:2.36
Close:2.39
52wk High:3.60
52wk Low:0.6617
Shares:227.38M
Float Shares:183.82M
Volume Ratio:0.59
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6118
EPS(LYR):-0.2499
ROE:-783.37%
ROA:-29.63%
PB:-11.93
PE(LYR):-9.68

Loading ...

EXPLAINER-How companies are steering IPO plans amid US government shutdown

Reuters
·
Oct 07

Wedbush Adjusts Gossamer Bio Price Target to $6 From $5, Maintains Outperform Rating

MT Newswires Live
·
Sep 25

Sector Update: Health Care Stocks Decline Premarket Thursday

MT Newswires Live
·
Sep 25

Gossamer Bio Issues 2.5M Shares for Merger Option, Plans Additional 1.5M Shares and Up to 6.7M in Milestone Stock Payments

Reuters
·
Sep 25

Respira Therapeutics Enters Into Agreement With Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira From Samsara Biocapital

THOMSON REUTERS
·
Sep 25

Press Release: Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital

Dow Jones
·
Sep 25

Gossamer Bio - Shareholders of Respira Eligible for Some Milestone Payments and High Single‑Digit Royalty on Potential Net Sales of Rt234

THOMSON REUTERS
·
Sep 25

Gossamer Bio Inc - IF Option Is Exercised, Gossamer Does Not Expect to Commence Clinical Trials of Rt234 Until at Least 2027

THOMSON REUTERS
·
Sep 25

Gossamer Bio Inc - to Issue 2.5 Mln Shares, 1.5 Mln More on Option Exercise

THOMSON REUTERS
·
Sep 25

Gossamer Bio Enters Into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, Rt234, an Inhaled, on‑Demand Vardenafil for Pulmonary Hypertension

THOMSON REUTERS
·
Sep 25

Gossamer Bio Unveils New Clinical Insights into Seralutinib's Efficacy for Pulmonary Hypertension at ERS Congress 2025

Reuters
·
Sep 22

Gossamer Bio Announces Presentations at the European Respiratory Society (Ers) Congress 2025

THOMSON REUTERS
·
Sep 22

Cantor says has reinforced conviction on Gossamer Bio ahead of data readout

TIPRANKS
·
Sep 11

BRIEF-Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Sep 11

Gossamer Bio Inc. Announces Stock Option Inducement Plan for New Employees

Reuters
·
Sep 11

Gossamer Bio Shares Rise After UBS Upgrade, PT Increase

MT Newswires Live
·
Sep 11

Gossamer Bio Inc : UBS Raises to Buy From Neutral

THOMSON REUTERS
·
Sep 10

Gossamer Bio Raised to Buy From Neutral by UBS

Dow Jones
·
Sep 10

Gossamer Bio Inc. Unveils Presentation Highlighting Innovative Therapies for Pulmonary Hypertension and Progress on Seralutinib Trials

Reuters
·
Sep 03

Gossamer Bio Inc. to Present at Cantor Global Healthcare Conference in New York

Reuters
·
Aug 29